PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.\', \'Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.\', \'Department of Biostatistics, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.\', \'Division of Medical Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.\', \'Department of Surgical Oncology, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cncr.32968
?:doi
?:hasPublicationType
?:journal
  • Cancer
is ?:pmid of
?:pmid
?:pmid
  • 32478895
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.455
?:rankingScore_hIndex
  • 265
is ?:relation_isRelatedTo_publication of
?:title
  • Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all